ADC Therapeutics S.A. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 11/14/2025 | 15.67 M | $62.67 M | 0.00% | 13.77% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 8.14 M | $32.54 M | 4.79% | 7.15% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 7.47 M | $29.89 M | -28.62% | 6.57% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 5.91 M | $23.63 M | 0.00% | 5.19% |
| BLACKROCK, INC. | 11/12/2025 | 4.51 M | $18.05 M | -0.21% | 3.97% |
| MORGAN STANLEY | 11/14/2025 | 3.67 M | $14.68 M | 20.47% | 3.23% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.27 M | $9.07 M | 0.00% | 1.99% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.59 M | $6.38 M | 3.36% | 1.40% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 1.39 M | $5.56 M | 100.00% | 1.22% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.36 M | $5.45 M | -38.10% | 1.20% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 1.33 M | $5.30 M | 100.00% | 1.17% |
| STATE STREET CORP | 11/14/2025 | 1.30 M | $5.18 M | 4.98% | 1.14% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/13/2025 | 1.16 M | $4.63 M | -16.62% | 1.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 862.93 K | $3.45 M | 0.48% | 0.76% |
| CITADEL ADVISORS LLC | 11/14/2025 | 820.72 K | $3.28 M | 2,729.47% | 0.72% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 733.57 K | $2.93 M | 0.00% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 701.62 K | $2.81 M | 82.87% | 0.62% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 688.47 K | $2.75 M | 15.17% | 0.61% |
| VANTAGE CONSULTING GROUP INC | 11/06/2025 | 683.00 K | $2.73 M | 0.00% | 0.60% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 682.53 K | $2.73 M | 100.00% | 0.60% |
| VANGUARD GROUP INC | 11/07/2025 | 593.95 K | $2.38 M | 5.96% | 0.52% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 544.26 K | $2.18 M | 100.57% | 0.48% |
| JANE STREET GROUP, LLC | 11/14/2025 | 487.87 K | $1.95 M | 100.00% | 0.43% |
| NORTHERN TRUST CORP | 11/14/2025 | 417.57 K | $1.67 M | -2.18% | 0.37% |
| JPMORGAN CHASE & CO | 11/26/2025 | 330.60 K | $1.32 M | 865.33% | 0.29% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 11/18/2025 | 326.77 K | $1.31 M | -88.47% | 0.29% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 283.29 K | $1.13 M | 0.00% | 0.25% |
| UBS GROUP AG | 11/13/2025 | 262.26 K | $1.05 M | -68.31% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 250.08 K | $1.00 M | 100.00% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 182.01 K | $728.05 K | 0.00% | 0.16% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 227.50 K | $906.00 K | 100.00% | 0.20% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 177.03 K | $708.13 K | 100.00% | 0.16% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 174.94 K | $699.77 K | 550.76% | 0.15% |
| NUVEEN, LLC | 11/12/2025 | 171.23 K | $684.92 K | 43.99% | 0.15% |
| MARSHALL WACE, LLP | 11/13/2025 | 159.99 K | $639.97 K | 100.00% | 0.14% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 158.69 K | $634.77 K | 0.35% | 0.14% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 145.25 K | $581.01 K | 3.32% | 0.13% |
| FMR LLC | 11/13/2025 | 133.43 K | $533.71 K | 1.18% | 0.12% |
| BARCLAYS PLC | 11/12/2025 | 130.46 K | $521.84 K | -10.28% | 0.11% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 122.08 K | $488.32 K | 0.00% | 0.11% |
| SANIBEL CAPTIVA TRUST COMPANY, INC. | 10/29/2025 | 113.00 K | $452.00 K | 0.00% | 0.10% |
| CREATIVE PLANNING | 11/14/2025 | 106.65 K | $426.60 K | 196.26% | 0.09% |
| RHUMBLINE ADVISERS | 11/06/2025 | 100.47 K | $401.90 K | -2.08% | 0.09% |
| BRYN MAWR TRUST CO | 11/20/2025 | 100.00 K | $400.00 K | 0.00% | 0.09% |
| XTX TOPCO LTD | 11/14/2025 | 91.58 K | $366.32 K | 100.00% | 0.08% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 77.52 K | $310.10 K | 38.28% | 0.07% |
| VOLEON CAPITAL MANAGEMENT LP | 11/14/2025 | 70.31 K | $281.24 K | 100.00% | 0.06% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 69.50 K | $278.00 K | 11.31% | 0.06% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 64.52 K | $258.09 K | 48.58% | 0.06% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 49.59 K | $198.36 K | 0.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ADC Therapeutics S.A. institutional Ownership - FAQ's
During the previous two years, 117 institutional investors and hedge funds held shares of ADC Therapeutics S.A.. The most heavily invested institutionals were:
Redmile Group, LLC: 15.67 M
Point72 Asset Management, L.P.: 8.14 M
Prosight Management, LP: 7.47 M
ORBIMED ADVISORS LLC: 5.91 M
BlackRock, Inc.: 4.51 M
MORGAN STANLEY: 3.67 M
59.64% of ADC Therapeutics S.A. stock is owned by institutional investors.
Institutional investors have bought a total of 74.45 M shares in the last 24 months. This purchase volume represents approximately $247.92 M in transactions.